These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 6309504

  • 1. Effects of arginine-8-vasopressin and 1-deamino-8-D-arginine-vasopressin on ACTH secretion in rats.
    László FA, Janáky T, Julesz J, Kárteszi M, Makara GB, Stark E.
    Endocrinol Exp; 1983 Jun; 17(2):133-6. PubMed ID: 6309504
    [Abstract] [Full Text] [Related]

  • 2. Studies of the nature of the interaction between vasopressin and corticotropin-releasing factor on adrenocorticotropin release in the rat.
    Rivier C, Rivier J, Mormede P, Vale W.
    Endocrinology; 1984 Sep; 115(3):882-6. PubMed ID: 6086290
    [Abstract] [Full Text] [Related]

  • 3. Evidence that the effects of arginine-8-vasopressin (AVP) on pituitary corticotropin (ACTH) release are mediated by a novel type of receptor.
    Antoni FA, Holmes MC, Makara GB, Kárteszi M, László FA.
    Peptides; 1984 Sep; 5(3):519-22. PubMed ID: 6089144
    [Abstract] [Full Text] [Related]

  • 4. [1-deamino-4-cyclohexylalanine] arginine vasopressin: a potent and specific agonist for vasopressin V1b receptors.
    Derick S, Cheng LL, Voirol MJ, Stoev S, Giacomini M, Wo NC, Szeto HH, Ben Mimoun M, Andres M, Gaillard RC, Guillon G, Manning M.
    Endocrinology; 2002 Dec; 143(12):4655-64. PubMed ID: 12446593
    [Abstract] [Full Text] [Related]

  • 5. Influence of nitric oxide synthase inhibitors on the vasopressin-induced pituitary-adrenocortical activity and hypothalamic catecholamine levels.
    Bugajski J, Gadek-Michalska A, Głód R, Borycz J.
    J Physiol Pharmacol; 1998 Dec; 49(4):617-26. PubMed ID: 10069702
    [Abstract] [Full Text] [Related]

  • 6. Dose-dependent stimulation of renal prostaglandin synthesis by deamino-8-D-arginine vasopressin in rats with hereditary diabetes insipidus.
    Walker LA, Frölich JC.
    J Pharmacol Exp Ther; 1981 Apr; 217(1):87-91. PubMed ID: 7205662
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Specific receptors for vasopressin in the pituitary gland: evidence for down-regulation and desensitization to adrenocorticotropin-releasing factors.
    Koch B, Lutz-Bucher B.
    Endocrinology; 1985 Feb; 116(2):671-6. PubMed ID: 2981673
    [Abstract] [Full Text] [Related]

  • 9. A novel type of vasopressin receptor on anterior pituitary corticotrophs?
    Baertschi AJ, Friedli M.
    Endocrinology; 1985 Feb; 116(2):499-502. PubMed ID: 2981663
    [Abstract] [Full Text] [Related]

  • 10. Inferior petrosal sinus sampling in healthy subjects reveals a unilateral corticotropin-releasing hormone-induced arginine vasopressin release associated with ipsilateral adrenocorticotropin secretion.
    Kalogeras KT, Nieman LK, Friedman TC, Doppman JL, Cutler GB, Chrousos GP, Wilder RL, Gold PW, Yanovski JA.
    J Clin Invest; 1996 May 01; 97(9):2045-50. PubMed ID: 8621793
    [Abstract] [Full Text] [Related]

  • 11. Effects of lysine-vasopressin (LVP) and 1-deamino-8-D-arginine-vasopressin (dDAVP) upon electrical potential, short-circuit current and transepithelial D.C. resistance of the frog skin.
    Bakos P, Ponec J, Lichardus B.
    Gen Physiol Biophys; 1984 Aug 01; 3(4):297-305. PubMed ID: 6094299
    [Abstract] [Full Text] [Related]

  • 12. The effects of subcutaneous administration of arginine-8-vasopressin on the electroencephalogram of conscious rats are mediated by peripheral vasopressin V1 receptors.
    Ebenezer IS.
    Methods Find Exp Clin Pharmacol; 1994 Jun 01; 16(5):315-21. PubMed ID: 7934310
    [Abstract] [Full Text] [Related]

  • 13. DDAVP (1-desamino-8-D-arginine vasopressin): an antagonist of the pressor action of endogenous vasopressin?
    Derkx FH, Man in 't Veld AJ, Jones R, Reid JL, Schalekamp MA.
    J Hypertens Suppl; 1983 Dec 01; 1(2):58-61. PubMed ID: 6400119
    [Abstract] [Full Text] [Related]

  • 14. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
    Swain MG, Patchev V, Vergalla J, Chrousos G, Jones EA.
    J Clin Invest; 1993 May 01; 91(5):1903-8. PubMed ID: 8387536
    [Abstract] [Full Text] [Related]

  • 15. [Role of the neurohypophysis in psychological stress].
    Scantamburlo G, Ansseau M, Legros JJ.
    Encephale; 2001 May 01; 27(3):245-59. PubMed ID: 11488255
    [Abstract] [Full Text] [Related]

  • 16. Normal acid-base equilibrium in acute hyponatremia and mixed alkalosis in chronic hyponatremia induced by arginine vasopressin or 1-deamino-8-D-arginine vasopressin in rats.
    Decaux G, Crenier L, Namias B, Gervy C, Soupart A.
    J Lab Clin Med; 1994 Jun 01; 123(6):892-8. PubMed ID: 8201268
    [Abstract] [Full Text] [Related]

  • 17. Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis.
    Jard S, Gaillard RC, Guillon G, Marie J, Schoenenberg P, Muller AF, Manning M, Sawyer WH.
    Mol Pharmacol; 1986 Aug 01; 30(2):171-7. PubMed ID: 3016500
    [Abstract] [Full Text] [Related]

  • 18. Arginine vasopressin and adrenocorticotropin release: correlation between binding characteristics and biological activity in anterior pituitary dispersed cells.
    Spinedi E, Negro-Vilar A.
    Endocrinology; 1984 Jun 01; 114(6):2247-51. PubMed ID: 6327240
    [Abstract] [Full Text] [Related]

  • 19. V2 receptor antagonism of DDAVP-induced release of hemostasis factors in conscious dogs.
    Bernat A, Hoffmann P, Dumas A, Serradeil-le Gal C, Raufaste D, Herbert JM.
    J Pharmacol Exp Ther; 1997 Aug 01; 282(2):597-602. PubMed ID: 9262320
    [Abstract] [Full Text] [Related]

  • 20. Characteristics of the receptors which mediate the stimulation of ACTH secretion by vasopressin in conscious dogs.
    Schwartz J, Reid IA.
    Neuroendocrinology; 1986 Aug 01; 42(2):93-6. PubMed ID: 3005898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.